Dann, Eldad J. 2020. “Response to Comment On: ‘Is It Time to Reduce the Doxorubicin Dosage in Hodgkin Lymphoma therapy?’”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.301249.